From Health Affairs Sunday Update <[email protected]>
Subject New Issue Released This Week
Date May 7, 2023 2:06 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Markets, Payments, And More
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌


Problems viewing this email?

View Message In Browser
<[link removed]>

Sunday, May 7, 2023 | The Latest Research, Commentary, And News From
Health Affairs

Dear John,

We've announced several new events for May, including a Policy Spotlight
with Dawn O'Connell
<[link removed]>,
assistant secretary for preparedness and response, US Department of
Health and Human Services. Take a look at what else is upcoming this
month
<[link removed]>.

[link removed]


The May issue of Health Affairs covers a broad range of topics: how
markets affect prices and utilization, how government payment policies
affect health system behavior, the implications of inequities in
preventable heart failure admissions in the US South, and more.

Featured articles include:

* The Role Of Financial Incentives In Biosimilar Uptake In Medicare:
Evidence From The 340B Program
<[link removed]>;
Amelia Bond of Weill Cornell Medicine and coauthors.

* Hospital-Physician Integration Is Associated With Greater Use Of
Cardiac Catheterization And Angioplasty
<[link removed]>;
Brady Post from Northeastern University and coauthors.

* Availability Versus Accessibility: Identifying COVID-19 Testing
Deserts Across Massachusetts
<[link removed]>;
Caitlin Radford of Weill Cornell Medicine and coauthors.

Read More
<[link removed]>


 

[link removed]


Advertisement

 

[link removed]


A Health Podyssey: Amelia Bond On 340B's Influence On Biosimilars
<[link removed]>

Health Affairs Editor-in-Chief Alan Weil interviews Amelia Bond from
Weill Cornell Medical College on her paper exploring whether
participation in the 340B drug program influences biosimilar uptake.

This Week: Kaiser, Geisinger, And the Uncertain Future Of Value-Based
Care
<[link removed]>
Listen to Health Affairs' Leslie Erdelack and Michael Gerber discuss the
newly announced merger between Kaiser Permanente and Geisinger Health
System.

 

[link removed]


Health Affairs is launching a contest! The premise is simple. Finish the
statement "You're A Health Policy Wonk If..."

We'll share some of the submissions on Forefront in July, and the
first-place winner of the contest will receive a Health Affairs tumbler
and a free Unlimited membership
<[link removed]>
for a year. Submit by May 31
<[link removed]>.

 

Medicare's 'Coverage With Evidence Development': A Barrier To Patient
Access And Innovation
<[link removed]>

Joe Grogan

Clinical Implications Of The Braidwood Ruling: Use Of Pre-ACA Task Force
Recommendations
<[link removed]>

Zoey Chopra and A. Mark Fendrick

Medicare Price Negotiation: The Example Of Ibrutinib
<[link removed]>

Adam J. N. Raymakers et al.

Forcing States To Tie Medicaid To Work Is An Unconstitutional 'Gun To
The Head'
<[link removed]>

Sara Rosenbaum et al.

The High Costs Of Ignoring Health Inequities
<[link removed]>

Andrew C. Anderson

Will Technology Such As ChatGPT Improve Health Care Or Exacerbate
Disparities?
<[link removed]>

Wura Jacobs and Omolola E. Adepoju

A Strategy For Value-Based Drug Pricing Under The Inflation Reduction
Act
<[link removed]>

Jason Shafrin et al.

Why International Recruitment Won't Solve The US Nursing Staffing
Crisis
<[link removed]>

Y. Tony Yang et al.

Identifying Scalable Strategies To Maintain Coverage As Medicaid
Continuous Enrollment Ends
<[link removed]>

Rebecca Myerson and Laura Dague

The Health Plan Price Transparency Data Files Are a Mess-States Can
Help Make Them Better
<[link removed]>

Sabrina Corlette

 

[link removed]

Test your health policy knowledge today on the question below:

What is the 340B Drug Pricing Program?

* A guideline for pharmaceutical pricing

* An index of biosimilars available in the US market

* A program that offers eligible hospitals substantial discounts on drug
purchases

Answer <[link removed]>

[link removed]


 

About Health Affairs

Health Affairs is the leading peer-reviewed journal
<[link removed]> at the
intersection of health, health care, and policy. Published monthly by
Project HOPE, the journal is available in print and online.
Late-breaking content is also found through healthaffairs.org
<[link removed]>, Health Affairs Today
<[link removed]>, and Health Affairs Sunday
Update <[link removed]>.  

Project HOPE <[link removed]> is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy <[link removed]>

To unsubscribe from this email, update your email preferences here
<[link removed]>.

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]
_________________

Sent to [email protected]

Unsubscribe:
[link removed]

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States
Screenshot of the email generated on import

Message Analysis